Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?

Pediatric Nephrology

Volumn 22, Issue 11, 2007, Pages 1931-1938

  Saarinen, Tuure T ^a   Arikoski, Pekka ^b   Holmberg, Christer ^a   Rönnholm, Kai ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Children; Congenital nephrosis; End stage renal failure; Growth; Parathyroid hormone (PTH); Vitamin D analogue treatment

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CALCITRIOL; CALCIUM CARBONATE; IRON; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; CATCH UP GROWTH; CHILD; CLINICAL ARTICLE; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG INTERMITTENT THERAPY; FEMALE; HUMAN; INFANT; KIDNEY FAILURE; MALE; NEPHRECTOMY; NUTRITIONAL SUPPORT; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RETROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; VITAMIN SUPPLEMENTATION;

BONE DENSITY CONSERVATION AGENTS; CHILD DEVELOPMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHOLECALCIFEROLS; HYPERALGESIA; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; NEPHROSIS; PARATHYROID HORMONE; PERITONEAL DIALYSIS; RENAL OSTEODYSTROPHY; RETROSPECTIVE STUDIES;

EID: 34848888633     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0592-1     Document Type: Article

References (37)

1. Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975-982
2. Sherrad DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43:436-442
3. Fivush BA, Jabs K, Neu AM, Sullivan EK, Feld L, Kohaut E, Fine R (1998) Chronic renal insufficiency in children and adolescents: The 1996 annual report of NAPRTCS. Pediatr Nephrol 12:328-337
4. Kuizon BD, Salusky IB (1999) Growth retardation in children with chronic renal failure. J Bone Miner Res 14:1680-1690
5. Holmberg C, Antikainen M, Rönnholm K, Ala-Houhala M, Jalanko H (1995) Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 9:87-93
6. Salusky IB, Goodman WG (1996) The management of renal osteodystrophy. Pediatr Nephrol 10:651-655
7. Drueke TB (1999) Medical management of secondary hyperparathyroidism in uremia. Am J Med Sci 317:383-389
8. Herrmann P, Ritz E, Schmidt-Gayk H, Schafer I, Geyer J, Nonnast-Daniel B, Koch KM, Weber U, Hohrl W, Haas-Worle A, Kühn K, Bierther B, Schneider P (1994) Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: A randomized prospective trial. Nephron 67:48-53
9. Ala-Houhala M, Holmberg C, Ronnholm K, Paganus A, Laine J, Koskimies O (1995) Alphacalcidol oral pulses normalize uremic hyperparathyroidism prior to dialysis. Pediatr Nephrol 9:737-741
10. Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA (1994) Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710-1721
11. Levine BS, Song M (1996) Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol 7:488-496
12. Panichi V, Andreini B, DePietro S, Migliori M, Taccola D, Giovannini L, Ferdeghini M, Palla R (1998) Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialysis renal failure. Clin Nephrol 49:245-250
13. Schmitt CP, Ardissino G, Testa S, Claris-Appiani A, Mehls O, The European Study Group on Vitamin D in Children with Chronic Renal Failure (2003) Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18:440-444
14. Antikainen M, Holmberg C, Taskinen M-R (1992) Growth, serum lipoproteins and apoproteins in infants with congenital nephrosis. Clin Nephrol 38:254-263
15. Hölttä T, Rönnholm K, Jalanko H, Holmberg C (2000) Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control. Pediatr Nephrol 14:889-897
16. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166
17. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205-211
18. Kuizon BD, Salusky IB (1998) Intermittent calcitriol therapy and growth in children with chronic renal failure. Miner Electrolyte Metab 24:290-295
19. Fournier A, Oprisiu R, El Esper N, Moriniere P (1995) Optimal plasma concentrations of intact parathyroid hormone in predialysis patients. Nephrol Dial Transplant 10:2376-2378
20. Felsenfeld AJ (1997) Considerations for the treatment of secondary hyperparathyroidism in renal failure. J Am Soc Nephrol 8:993-1004
21. Waller S, Ledermann S, Trompeter R, van't Hoff W, Ridout D, Rees L (2003) Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol 18:1236-1241
22. Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y (1995) Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836-844
23. Ridgen SP (1996) The treatment of renal osteodystrophy. Pediatr Nephrol 10:653-655
24. Klaus G, Watson A, Edefonti A, Fischbach M, Rönnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schröder C, Zurowska A, Ekim M (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151-159
25. Yalçnkaya F, Tümer N, Öakar N, Özkaya N (1997) Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol 11:350-352
26. Hölttä T, Rönnholm K, Holmberg C (2000) Adequacy of dialysis with tidal and continuous cycling peritoneal dialysis in children. Nephrol Dial Transplant 15:1438-1442
27. Hölttä T, Rönnholm K, Jalanko H, Ala-Houhala M, Antikainen M, Holmberg C (1997) Peritoneal dialysis in children under 5 years of age. Perit Dial Int 17:573-580
28. Huttunen N-P (1976) Congenital nephrotic syndrome of the Finnish type. Study of 75 patients. Arch Dis Child 51:344-348
29. Antikainen M (1993) Protein and lipid metabolism in nephrotic infants on peritoneal dialysis after nephrectomy. Pediatr Nephrol 7:428-433
30. Ardissino G, Schmitt CP, Testa S, Claris-Appiani A, Mehls O for the European Study Group on Vitamin D in Children with Renal Failure (2000) Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. Pediatr Nephrol 14:664-668
31. Klaus G, Meinhold-Heerlein R, Milde P, Ritz E, Mehls O (1991) Effect of vitamin D on growth cartilage cell proliferation in vitro. Pediatr Nephrol 5:461-466
32. Sanchez CP, Yu-Zhu H (2005) Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism. J Am Soc Nephrol 16:929-938
33. Tam CS, Heersche JNM, Murray TM, Parsons JA (1982) Parathyroid hormone stimulates the bone apposition rate independently of its resorption action: Differential effects of intermittent and continuous administration. Endocrinology 110:506-512
34. Gunness-Hey M, Hock JM (1984) Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis 5:177-180
35. Schmitt CP, Hessing S, Oh J, Weber L, Ochlich P, Mehls O (2000) Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats. Kidney Int 57:1484-1492
36. Mehls O, Knöller N, Oh J, Wesch H, Wünsche B, Schmitt CP (2000) Daily but not pulse calcitriol therapy improves growth in experimental uremia. Pediatr Nephrol 14:658-663 Daily but not pulse calcitriol therapy improves growth in experimental uremia
37. Avila-Diaz M, Matos M, Garcia-Lopez E, Prado MD, Castro-Vazquez F, Ventura MD, Gonzalez E, Amato D, Paniagua R (2006) Serum markers of low turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis. Perit Dial Int 26:78-84